Novel use of the Amplatzer septal occluder device in the percutaneous closure of ascending aortic pseudoaneurysms: a case series.

Catheter Cardiovasc Interv

Cardiac Catheterization Laboratory, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Published: January 2007

Pseudoaneurysms of the ascending aorta are a potentially fatal condition that usually necessitates definitive surgical management. In this series of three cases, we describe the novel use of the Amplatzer septal occluder device in percutaneously managing this problem.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.20794DOI Listing

Publication Analysis

Top Keywords

novel amplatzer
8
amplatzer septal
8
septal occluder
8
occluder device
8
device percutaneous
4
percutaneous closure
4
closure ascending
4
ascending aortic
4
aortic pseudoaneurysms
4
pseudoaneurysms case
4

Similar Publications

Paravalvular leak (PVL) represents a common complication often encountered following valve replacement surgeries, posing significant diagnostic and therapeutic challenges within the field of cardiology. The condition, characterized by an abnormal flow of blood around the edges of a prosthetic valve, can lead to a spectrum of clinical manifestations, from asymptomatic states to severe heart failure or hemolysis. Its relevance is underscored by its contribution to morbidity and mortality among affected individuals, necessitating a deeper understanding of its etiology, diagnosis, and management.

View Article and Find Full Text PDF

Transcatheter PFO closure for cryptogenic stroke: current approaches and future considerations.

Front Cardiovasc Med

May 2024

Inova Schar Heart and Vascular, Inova Fairfax Medical Campus, Falls Church, VA, United States.

Patent Foramen Ovale (PFO) is a common congenital atrial septal defect present in 20%-35% of the general population. Although generally considered a benign anatomic variant, a PFO may facilitate passage of a thrombus from the venous to arterial circulation, thereby resulting in cryptogenic stroke or systemic embolization. A PFO is detected in nearly one half of patients presenting with cryptogenic stroke and often considered the most likely etiology when other causes have been excluded.

View Article and Find Full Text PDF

Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure.

BMC Cardiovasc Disord

March 2024

Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong District, Hunan Province, Changsha, 410011, People's Republic of China.

Background: Approximately 90% of intracardial thrombi originate from the left atrial appendage in non-valvular atrial fibrillation patients. Even with anticoagulant therapy, left atrial appendage thrombus (LAAT) still occurs in 8% of patients. While left atrial appendage closure (LAAC) could be a promising alternative, the current consensus considers LAAT a contraindication to LAAC.

View Article and Find Full Text PDF

Transcatheter Paravalvular Leak Closure With Covered Stent Tract and Vascular Plug: Tootsie Roll Technique.

JACC Cardiovasc Interv

March 2024

Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, Georgia, USA. Electronic address:

Background: Transcatheter closure of transcatheter heart valve (THV)-related paravalvular leak (PVL) is associated with a high failure rate with available devices due to the complex interaction of THV and aortic/mitral annulus.

Objectives: This study reports on novel transcatheter techniques to treat PVL after THV.

Methods: The authors describe consecutive patients who underwent PVL closure after transcatheter aortic valve replacement (TAVR) or transcatheter mitral valve replacement (TMVR).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!